Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
about
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cellsFrom HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cellsDual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African AmericansERBB2 increases metastatic potentials specifically in androgen-insensitive prostate cancer cells.Dysregulated expression of growth factors and their receptors in the development of prostate cancer.c-erbB3 protein expression in ovarian cancer.Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.Novel strategies and therapeutics for the treatment of prostate carcinoma.Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.High-grade prostatic intraepithelial neoplasia.Matriptase is involved in ErbB-2-induced prostate cancer cell invasionContemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia.Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.Immunohistochemical assays in prostatic biopsies processed in Bouin's fixativeClinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cellsErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cellsTendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors.Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomyThe ERBB3 receptor in cancer and cancer gene therapyImmunohistochemical expression of rabphilin-3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas.Profiling serum HER-2/NEU in prostate cancer.Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens.CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus.Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP.The use of biomarker expression to characterize neoplastic processes.Involvement of the c-erbB-2 oncogene product in the EGF-induced cell motility of SK-OV-3 ovarian cancer cells.Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma.Changes in biomarker expression in the development of prostatic adenocarcinoma.Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.Expression of androgen receptor and growth factors in premalignant lesions of the prostate.Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis.Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells.Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
P2860
Q24317507-841B99C2-5821-4D40-9280-C1C7EC03BD26Q24682910-EA02CC0E-F541-4D21-8035-3EEC7C48F584Q24817218-04A099A8-CF7E-4DA1-802E-35EA2EFCF301Q27008271-1F1B14E6-3A3E-42C2-9A06-DF27CB1EAADDQ33768865-276BFF04-B6F5-4D74-8DA7-AD49B6B03411Q33807246-EC48DACA-E1E3-471B-81FB-2C9F75B3E8E3Q33841195-E52B1091-E7BD-4DB8-8A51-07C3D228B250Q33960695-878F0CD0-FD92-4D49-8C6F-5B6662FFF99EQ34043331-48E5C211-1290-48D9-99F0-213F490488C5Q34122915-F7CB4F4A-FF3A-40E8-B957-4310C7BD009BQ34291962-115B1FF8-A32D-4836-AD41-75BA2866DE2EQ34358331-EFB248E5-BF6E-488F-B9D2-8ECA3006CBDDQ34696497-8651729C-433A-4F7C-9260-A694E9408237Q34982720-A1EAD8CB-3EE1-4516-B88C-6FC536975BAAQ35588427-6C41985B-67E2-4763-96E6-6AEA5254A104Q35662393-11F3C120-B769-4A80-BBA9-240D278368BFQ35788601-158C74DF-5A25-46D6-BDAC-8426EDD62D17Q36025400-AF6BB7FA-1D3D-4FE6-A223-68A2A1CE1244Q36048017-C1868E96-C2AA-46B6-85A7-FB432DB780ECQ36475900-AF991F3B-75E1-4268-8EB4-22363D7295BDQ36921877-AF876E0B-BEE0-408C-9A17-21C9B98A7C4AQ37120344-172E722F-A6E8-4BA4-950A-AF1A8D1F4C8CQ37135372-C381F3C9-7F35-426F-9EBE-9E60C161D892Q37155313-8205A727-C944-45A0-B73E-0918DDACE608Q38174595-DAECB1DA-3CC5-4DA5-AC43-E49114C3CCB9Q38477183-7BC00893-A35B-43BF-9432-E83124DC1740Q38477329-4AAEF05D-09B6-4FCA-9E4F-4E6746B3BA5DQ39241785-8A999C5A-7B88-4731-B63B-C3734110DA99Q39841601-D8DAD4C0-E8B4-41A3-A0DF-726AFEA3EEBBQ40652497-73F45A71-E893-4476-8202-AED7A17777E5Q40901765-200B4341-3E92-405E-8762-4F3E95569AF6Q40927519-59C67A92-EED3-48D1-8E39-25C88DBD3338Q40996353-59630619-C275-422B-A31E-9E92C0BB9804Q41471192-3A6881FF-94EA-41A9-8A29-3E8F76CCF3C8Q42120683-37CA9CCC-D05C-493B-B124-B0C105A0641EQ42467183-C3E1218E-A6A7-4F97-8B3C-82D19A2FE7D9Q42525575-6F4A5561-A18F-4179-86B2-4A60C969D19AQ43603245-CE821FB6-FF62-454D-841B-6F4C77DBB52AQ44168590-CA3A708B-E287-4011-BE7D-E89B946E533AQ44304000-9BEDF06D-8E89-4E5A-B21C-B4271C1B0347
P2860
Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@en
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@nl
type
label
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@en
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@nl
prefLabel
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@en
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@nl
P2093
P356
P1476
Expression of p160erbB-3 and p ...... and prostatic adenocarcinoma.
@en
P2093
Grizzle WE
Oelschlager DK
Srivastava S
P304
P356
10.1093/JNCI/86.15.1140
P407
P577
1994-08-01T00:00:00Z